Texas 2023 88th Regular

Texas Senate Bill SB265 Introduced / Bill

Filed 12/06/2022

                    88R2337 KKR-D
 By: Perry S.B. No. 265


 A BILL TO BE ENTITLED
 AN ACT
 relating to required reports of certain vaccine-related or
 drug-related injuries and adverse events.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter A, Chapter 161, Health and Safety
 Code, is amended by adding Section 161.0103 to read as follows:
 Sec. 161.0103.  REQUIRED REPORT OF CERTAIN VACCINE-RELATED
 INJURIES AND ADVERSE EVENTS.  (a)  This section applies only to a
 vaccine that is:
 (1)  experimental or investigational; or
 (2)  approved or authorized for emergency use by the
 United States Food and Drug Administration.
 (b)  Notwithstanding any other law, for a vaccine to which
 this section applies a physician shall report to the federal
 Vaccine Adverse Event Reporting System:
 (1)  each potential vaccine-related injury of a patient
 the physician treats; and
 (2)  any adverse event following the patient's
 vaccination.
 (c)  A physician who violates this section is subject to
 disciplinary action by the Texas Medical Board as if the physician
 violated Subtitle B, Title 3, Occupations Code.
 (d)  The executive commissioner shall adopt rules necessary
 to implement this section.
 SECTION 2.  Subchapter E, Chapter 431, Health and Safety
 Code, is amended by adding Section 431.1145 to read as follows:
 Sec. 431.1145.  REQUIRED REPORT OF CERTAIN DRUG-RELATED
 INJURIES AND ADVERSE EVENTS.  (a)  This section applies only to a
 drug that is:
 (1)  experimental or investigational; or
 (2)  approved or authorized for emergency use by the
 United States Food and Drug Administration.
 (b)  Notwithstanding any other law, for a drug to which this
 section applies a physician shall report to the United States Food
 and Drug Administration through the MedWatch Reporting System:
 (1)  each potential drug-related injury of a patient
 the physician treats; and
 (2)  any adverse event following the administration or
 use of the drug.
 (c)  A physician who violates this section is subject to
 disciplinary action by the Texas Medical Board as if the physician
 violated Subtitle B, Title 3, Occupations Code.
 (d)  The executive commissioner shall adopt rules necessary
 to implement this section.
 SECTION 3.  As soon as practicable after the effective date
 of this Act, the executive commissioner of the Health and Human
 Services Commission shall adopt rules necessary to implement the
 changes in law made by this Act.
 SECTION 4.  This Act takes effect September 1, 2023.